| 12-Aug-2015 | S | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2015,has considered and approved the sub-division (split) of one equity share of the Company having a face value of Rs. 5/- into five equity shares of face of Rs. 1/- each.
The sub-division of shares will be subject to approval by the shareholders, which will be sought by postal ballot, and any other statutory and regulatory approvals. Accordingly, the record date for sub-division of shares will be announced in due course.
SUB. :- Sub Division of equity shares of Cadila Healthcare Limited (Scrip Code 532321)
Trading Members of the Exchange are hereby informed that, Cadila Healthcare Limited has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Cadila Healthcare Limited
(432321; 532321;632321)
RECORD DATE
07/10/2015
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.5/- each into FIVE equity shares of Re.1/- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
06/10/2015 DR-130/2015-2016
Note:-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re. 1/- paid up w.e.f. 06/10/2015.
ii. ISIN No. INE010B01019 of Rs.5/- paid up will not be valid for transactions done on the Exchange on or after 06/10/2015.
iii. The new ISIN Number for Re.1- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 24.09.2015) | 07-Oct-2015 | |
| 17-May-2024 | D | Final dividend
The Board of Directors at their meeting held today have recommended final dividend of Rs.3.00/- (@300%) per equity share of Re. 1/- each, subject to approval of the shareholders at the ensuing Annual General Meeting scheduled to be held on August 9, 2024 | 26-Jul-2024 | |
| 18-May-2023 | D | The Board of Directors at their meeting held today have recommended final dividend of Rs. 6.00/- (@ 600%) per equity share of Re. 1/- each, subject to approval of the shareholders at the ensuing Annual General Meeting scheduled to be held on August 11, 2023.
Record Date For Final Dividend - July 28, 2023 | 28-Jul-2023 | |
| 20-May-2022 | D | Board approves the dividend
The Board of Directors at their meeting held today have recommended final dividend of Rs. 2.50/- (@ 250%) per equity share of Re. 1/- each, subject to approval of the shareholders at the ensuing Annual General Meeting scheduled to be held on August 10, 2022.
| 28-Jul-2022 | |
| 27-May-2021 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2021, inter alia, have recommended final dividend of Rs. 3.50/- (@ 350%) per equity share of Re. 1/- each, subject to approval of the
shareholders at the ensuing Annual General Meeting scheduled to be held on August 11, 2021. | 28-Jul-2021 | |
| 16-Mar-2020 | D | Interim Dividend for the financial year 2019-2020 | 23-Mar-2020 | |
| 29-May-2019 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 29, 2019, inter alia, have recommended a dividend of Rs. 3.50 [@ 350%] per equity share on 1,023,742,600 equity shares of Re. 1/-each for the financial year ended on March 31, 2019. The recommended dividend is subject to the approval of the shareholders at the ensuing Annual General Meeting. | 25-Jul-2019 | |
| 24-May-2018 | D | The Board of Directors at their meeting held today have recommended final dividend of Rs. 3.50/- (350%) per equity share of Re. 1/- each, subject to approval of the shareholders at the ensuing Annual General Meeting scheduled to be held on August 13, 2018. | 31-Jul-2018 | |
| 07-Mar-2017 | D | Pursuant to SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, we inform that the Board of Directors at their meeting held today approved the payment of interim dividend at Rs.3.20/- per equity share on 1,023,742,600 Equity Share of Rs.1/- each for the Financial Year 2016-17. The Board of Directors in above meeting also fixed March 17, 2017 as the Record Date to ascertain the list of members entitled to receive the interim dividend declared by the Board of Directors. Further, the interim dividend shall be paid to the shareholders entitled thereto, on and from March 21, 2017. The interim dividend cheques will be posted on or after March 21, 2017 and within 30 days from the date of declaration of the interim dividend as provided in the Companies Act, 2013. | 16-Mar-2017 | |
| 08-Mar-2016 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 08, 2016, has declared an interim dividend of Rs. 3.20/- [i.e. @ of 320%] per Equity Share on 102,37,42,600 Equity Shares of Rs. 1/- each of the Company for the financial year 2015-2016.
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 13, 2016 has not recommended final dividend on the equity shares and the interim dividend declared on March 08, 216 is the final dividend on the equity shares of the Company for the financial Year ended on March 31, 2016.
(As Per BSE Announcement Dated on 13.05.2016) | 17-Mar-2016 | |
| 15-May-2015 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 15, 2015, inter alia, have recommended a dividend of Rs. 12/- (@ 240%) per equity share on 204,748,520 equity shares of Rs. 5/- on March 31, 2015. | 30-Jul-2015 | |
| 16-May-2014 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 16, 2014, inter alia, have recommended a dividend of Rs. 9 (@ 180%) per equity share of Rs. 5/- each for the financial year ended on March 31, 2014. | 17-Jul-2014 | |
| 30-May-2013 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has declared interim Dividend of Rs. 7.50 per equity share of Rs. 5/- each on 20,47,48,520 equity shares out of the profits for the year ended on March 31, 2013. | 11-Jun-2013 | |
| 10-May-2012 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 10, 2012, inter alia, has recommended a dividend of Rs. 7.50/- [@150%] per equity share on 204,748,520 equity shares of Rs. 5/- each for the financial year ended on March 31, 2012.
Cadila Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 30, 2012 to August 06, 2012 (both days inclusive) for the purpose of Payment of Dividend & 17th Annual General Meeting (AGM) of the Company to be held on August 06, 2012.
The Dividend, if declared by the members will be paid to the members on August 11, 2012.
(As Per BSE ANnouncement Website Dated on 10/05/2012) | 26-Jul-2012 | |
| 06-May-2011 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2011, inter alia, have recommended a Dividend of Rs. 6.25/- (@ 125%) per equity share on 204,748,520 equity shares of Rs. 5/- each for the financial year ended March 31, 2011. | 07-Jul-2011 | |
| 29-Apr-2010 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 29, 2010, inter alia, has recommended a dividend of Rs. 5/- per equity share [@ 100%] of Rs. 5/- each for the financial year ended on March 31, 2010. | 15-Jul-2010 | |
| 28-Apr-2009 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 28, 2009, inter alia, have recommended a dividend of Rs 4.50 per equity share on the increased capital of 13,64,99,013 equity shares of Rs 5/- each for the financial year ended March 31, 2009. | 16-Jul-2009 | |
| 29-Apr-2008 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 29, 2008, inter alia, has recommended a dividend of Rs 4.50 (@ 90%) per equity shares on equity shares of Rs 5/- each for the financial year ended March 31, 2008. | 10-Jul-2008 | |
| 26-Apr-2007 | D | Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 26, 2007, inter alia, has recommended a dividend of Rs 4 (@ 80%) per equity share on the increased capital of 1,25,613,708 equity shares of Rs 5/- each for the financial year ended March 31, 2007. | 12-Jul-2007 | |
| 12-Jul-2005 | D | 120% Final Dividend | 14-Jul-2005 | |
| 23-Mar-2010 | B | SUB. :- Bonus issue of Cadila Healthcare Ltd (Scrip Code: 532321)
Trading Members of the Exchange are hereby informed that, Cadila Healthcare Limited has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the company should be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Cadila Healthcare Ltd.
(532321)
RECORD DATE
06/04/2010
PURPOSE
1 (ONE) fully paid up Bonus equity share for every 2 (TWO) existing equity shares held.
Ex-Bonus basis from Date & Sett. No.
05/04/2010 DR-004/2010-2011
Trading Members of the Exchange are requested to take note of it. | 06-Apr-2010 | 1:2 |
| 08-Aug-2006 | B | Trading Members of the Exchange are hereby informed that, Cadila Healthcare Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the company should be on an ex-bonus basis with effect from the under mentioned date.
RECORD DATE
31/08/2006
PURPOSE
ONE fully paid-up Bonus equity share for every ONE existing equity shareheld.
Trading Members of the Exchange are requested to take note of it. | 31-Aug-2006 | 1:1 |
| 30-Oct-2024 | BC | Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve unaudited financial results for the quar | 12-Nov-2024 | |
| 17-May-2024 | BC | Annual General Meeting scheduled to be held on August 9, 2024
Annual Report for the FY 2023-2024
(As Per BSE Announcement Dated on: 11/07/2024)
Outcome of AGM
(As Per BSE Announcement D | 09-Aug-2024 | |
| 18-Jul-2024 | BC | Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve unaudited financial results for the quar | 09-Aug-2024 | |
| 09-Aug-2024 | BC | Change in director | 09-Aug-2024 | |
| 17-May-2024 | BC | Record date for final dividend | 26-Jul-2024 | |